These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16582851)

  • 21. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and outcome of graft resorption in anterior lumbar interbody fusion: using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Kayanja M; Orr RD
    Spine (Phila Pa 1976); 2014 Mar; 39(5):374-80. PubMed ID: 24299714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages.
    Burkus JK; Gornet MF; Dickman CA; Zdeblick TA
    J Spinal Disord Tech; 2002 Oct; 15(5):337-49. PubMed ID: 12394656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis.
    Roh JS; Yeung CA; Field JS; McClellan RT
    J Orthop Surg Res; 2013 Dec; 8():49. PubMed ID: 24373225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ISSLS prize winner: positron emission tomography and magnetic resonance imaging for monitoring interbody fusion with equine bone protein extract, recombinant human bone morphogenetic protein-2, and autograft.
    Foldager C; Bendtsen M; Zou X; Zou L; Olsen AK; Munk OL; Stødkilde-Jørgensen H; Bünger C
    Spine (Phila Pa 1976); 2008 Dec; 33(25):2683-90. PubMed ID: 19002076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone morphogenetic protein-2 and bone marrow aspirate with allograft as alternatives to autograft in instrumented revision posterolateral lumbar spinal fusion: a minimum two-year follow-up study.
    Taghavi CE; Lee KB; Keorochana G; Tzeng ST; Yoo JH; Wang JC
    Spine (Phila Pa 1976); 2010 May; 35(11):1144-50. PubMed ID: 20139805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.
    Burkus JK; Gornet MF; Schuler TC; Kleeman TJ; Zdeblick TA
    J Bone Joint Surg Am; 2009 May; 91(5):1181-9. PubMed ID: 19411467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
    Burkus JK; Dryer RF; Peloza JH
    J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between allograft plus demineralized bone matrix versus autograft in anterior cervical fusion. A prospective multicenter study.
    An HS; Simpson JM; Glover JM; Stephany J
    Spine (Phila Pa 1976); 1995 Oct; 20(20):2211-6. PubMed ID: 8545714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes and fusion rates following anterior lumbar interbody fusion with bone graft substitute i-FACTOR, an anorganic bone matrix/P-15 composite.
    Mobbs RJ; Maharaj M; Rao PJ
    J Neurosurg Spine; 2014 Dec; 21(6):867-76. PubMed ID: 25325176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report.
    Boden SD; Zdeblick TA; Sandhu HS; Heim SE
    Spine (Phila Pa 1976); 2000 Feb; 25(3):376-81. PubMed ID: 10703113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study.
    Vaccaro AR; Anderson DG; Patel T; Fischgrund J; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
    Spine (Phila Pa 1976); 2005 Dec; 30(24):2709-16. PubMed ID: 16371892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strut allograft union and remodeling using rhBMP-2 in a spinal corpectomy model.
    White KK; Bawa M; Ahn JS; Farnsworth CL; Faro FD; Mahar AT; Wedemeyer M; Garfin SR; Newton PO
    Spine (Phila Pa 1976); 2005 Jun; 30(12):1386-95. PubMed ID: 15959367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in early osteogenesis and bone micro-architecture in anterior lumbar interbody fusion with rhBMP-2, equine bone protein extract, and autograft.
    Foldager C; Bendtsen M; Nygaard JV; Zou X; Bünger C
    Bone; 2009 Aug; 45(2):267-73. PubMed ID: 19398044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study.
    Vaccaro AR; Lawrence JP; Patel T; Katz LD; Anderson DG; Fischgrund JS; Krop J; Fehlings MG; Wong D
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2850-62. PubMed ID: 19092614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis.
    Allen RT; Lee YP; Stimson E; Garfin SR
    Spine (Phila Pa 1976); 2007 Dec; 32(26):2996-3006. PubMed ID: 18091493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.